The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EQ | +27.88% | -77.23% | -25.6% | -91% |
| S&P | +16.23% | +94.45% | +14.22% | +144% |
Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March, 2017 and is headquartered in La Jolla, CA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | -100.0% |
| Gross Profit | -$0.03M | -100.2% |
| Gross Margin | 99.20% | -0.4% |
| Market Cap | $11.26M | -53.9% |
| Market Cap / Employee | $0.32M | 0.0% |
| Employees | 35 | -20.5% |
| Net Income | -$5.74M | -1326.3% |
| EBITDA | -$6.20M | -9432.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $11.50M | 4.0% |
| Accounts Receivable | $0.00M | -100.0% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.11M | -57.9% |
| Short Term Debt | $0.15M | -57.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -73.09% | -56.7% |
| Return On Invested Capital | -72.52% | 1.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$3.01M | -551.0% |
| Operating Free Cash Flow | -$3.01M | -512.7% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.31 | 1.14 | 0.73 | 1.06 | -8.13% |
| Price to Sales | 0.64 | 0.65 | 0.46 | 0.68 | 14.30% |
| Price to Tangible Book Value | 1.31 | 1.14 | 0.73 | 1.06 | -8.13% |
| Enterprise Value to EBITDA | -6.36 | -0.93 | 0.03 | -0.00 | -100.00% |
| Return on Equity | -19.5% | -38.8% | -88.3% | -146.9% | 336.41% |
| Total Debt | $0.50M | $0.38M | $0.30M | $0.26M | -57.47% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
